rs62390671

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001999.4(FBN2):​c.203C>T​(p.Ala68Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0411 in 1,610,132 control chromosomes in the GnomAD database, including 1,512 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A68S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.032 ( 89 hom., cov: 32)
Exomes 𝑓: 0.042 ( 1423 hom. )

Consequence

FBN2
NM_001999.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15O:1

Conservation

PhyloP100: 2.11

Publications

9 publications found
Variant links:
Genes affected
FBN2 (HGNC:3604): (fibrillin 2) The protein encoded by this gene is a component of connective tissue microfibrils and may be involved in elastic fiber assembly. Mutations in this gene cause congenital contractural arachnodactyly. [provided by RefSeq, Jul 2008]
FBN2 Gene-Disease associations (from GenCC):
  • congenital contractural arachnodactyly
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • carpal tunnel syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Franklin by Genoox
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • macular degeneration, early-onset
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015599728).
BP6
Variant 5-128537401-G-A is Benign according to our data. Variant chr5-128537401-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94020.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0321 (4887/152310) while in subpopulation NFE AF = 0.0465 (3162/68014). AF 95% confidence interval is 0.0451. There are 89 homozygotes in GnomAd4. There are 2250 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 4887 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBN2NM_001999.4 linkc.203C>T p.Ala68Val missense_variant Exon 1 of 65 ENST00000262464.9 NP_001990.2 P35556-1
FBN2XM_017009228.3 linkc.203C>T p.Ala68Val missense_variant Exon 1 of 64 XP_016864717.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBN2ENST00000262464.9 linkc.203C>T p.Ala68Val missense_variant Exon 1 of 65 1 NM_001999.4 ENSP00000262464.4 P35556-1

Frequencies

GnomAD3 genomes
AF:
0.0321
AC:
4887
AN:
152192
Hom.:
89
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0146
Gnomad AMI
AF:
0.109
Gnomad AMR
AF:
0.0231
Gnomad ASJ
AF:
0.0513
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00993
Gnomad FIN
AF:
0.0344
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0465
Gnomad OTH
AF:
0.0344
GnomAD2 exomes
AF:
0.0304
AC:
7288
AN:
239974
AF XY:
0.0307
show subpopulations
Gnomad AFR exome
AF:
0.0134
Gnomad AMR exome
AF:
0.0165
Gnomad ASJ exome
AF:
0.0593
Gnomad EAS exome
AF:
0.0000555
Gnomad FIN exome
AF:
0.0352
Gnomad NFE exome
AF:
0.0437
Gnomad OTH exome
AF:
0.0313
GnomAD4 exome
AF:
0.0420
AC:
61242
AN:
1457822
Hom.:
1423
Cov.:
32
AF XY:
0.0415
AC XY:
30068
AN XY:
725194
show subpopulations
African (AFR)
AF:
0.0133
AC:
445
AN:
33464
American (AMR)
AF:
0.0182
AC:
811
AN:
44616
Ashkenazi Jewish (ASJ)
AF:
0.0583
AC:
1519
AN:
26060
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.0132
AC:
1134
AN:
85790
European-Finnish (FIN)
AF:
0.0350
AC:
1775
AN:
50762
Middle Eastern (MID)
AF:
0.0144
AC:
83
AN:
5762
European-Non Finnish (NFE)
AF:
0.0479
AC:
53274
AN:
1111440
Other (OTH)
AF:
0.0365
AC:
2200
AN:
60248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3582
7163
10745
14326
17908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1966
3932
5898
7864
9830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0321
AC:
4887
AN:
152310
Hom.:
89
Cov.:
32
AF XY:
0.0302
AC XY:
2250
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0146
AC:
607
AN:
41592
American (AMR)
AF:
0.0231
AC:
353
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0513
AC:
178
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00973
AC:
47
AN:
4832
European-Finnish (FIN)
AF:
0.0344
AC:
365
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0465
AC:
3162
AN:
68014
Other (OTH)
AF:
0.0340
AC:
72
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
246
492
738
984
1230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0428
Hom.:
369
Bravo
AF:
0.0311
TwinsUK
AF:
0.0488
AC:
181
ALSPAC
AF:
0.0444
AC:
171
ESP6500AA
AF:
0.0139
AC:
61
ESP6500EA
AF:
0.0466
AC:
400
ExAC
AF:
0.0300
AC:
3635
Asia WGS
AF:
0.00549
AC:
19
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Apr 04, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala68Val in exon 1 of FBN2: This variant is not expected to have clinical signif icance because it has been identified in 4.7% (400/8582) of European American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs62390671). -

Sep 06, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital contractural arachnodactyly Benign:4Other:1
Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2014
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant classified as Uncertain significance and reported on 07-26-2013 by Emory Genetics Laboratory. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Feb 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Jun 03, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Ehlers-Danlos syndrome Benign:1
Jun 17, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Connective tissue disorder Benign:1
Apr 23, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T;.;T;T;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.76
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.73
T;.;.;T;T
MetaRNN
Benign
0.0016
T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.90
L;.;L;.;.
PhyloP100
2.1
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-1.3
N;.;N;N;N
REVEL
Benign
0.17
Sift
Benign
0.18
T;.;T;T;T
Sift4G
Benign
0.27
.;.;.;T;T
Polyphen
0.0
B;.;B;B;B
Vest4
0.057
MPC
0.23
ClinPred
0.0077
T
GERP RS
2.9
PromoterAI
0.046
Neutral
Varity_R
0.039
gMVP
0.58
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62390671; hg19: chr5-127873094; API